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Airway lining ﬂuid contains relatively high concentrations of nitrite, and arterial blood levels of nitrite
are higher than venous levels, suggesting the lung epithelium may represent an important source of
nitrite in vivo. To investigate whether lung epithelial cells possess the ability to convert NO to nitrite by
oxidation, and the effect of oxygen reactions on nitrite formation, the NO donor DETA NONOate was
incubated with or without A549 cells or primary human bronchial epithelial (HBE) cells for 24 h under
normoxic (21% O2) and hypoxic (1% O2) conditions. Nitrite production was signiﬁcantly increased under
all conditions in the presence of A549 or HBE cells, suggesting that both A549 and HBE cells have the
capacity to oxidize NO to nitrite even under low-oxygen conditions. The addition of oxyhemoglobin to
the A549 cell medium decreased the production of nitrite, consistent with NO scavenging limiting nitrite
formation. Heat-denatured A549 cells produced much lower nitrite and nitrate, suggesting an enzymatic
activity is required. This NO oxidation activity was highest in membrane-bound proteins with molecular
size o100 kDa. In addition, 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one and cyanide inhibited forma-
tion of nitrite in A549 cells. It has been shown that ceruloplasmin (Cp) possesses an NO oxidase and
nitrite synthase activity in plasma based on NO oxidation to nitrosonium cation. We observed that Cp is
expressed intracellularly in lung epithelial A549 cells and secreted into the medium under basal
conditions and during cytokine stimulation. However, an analysis of Cp expression level and activity
measured via p-phenylenediamine oxidase activity assay revealed very low activity compared with
plasma, suggesting that there is insufﬁcient Cp to contribute to detectable NO oxidation to nitrite in A549
cells. Additionally, Cp levels were knocked down using siRNA by more than 75% in A549 cells, with no
signiﬁcant change in either nitrite or cellular S-nitrosothiol formation compared to scrambled siRNA
control under basal conditions or cytokine stimulation. These data suggest that lung epithelial cells
possess NO oxidase activity, which is enhanced in cell-membrane-associated proteins and not regulated
by intracellular or secreted Cp, indicating that alternative NO oxidases determine hypoxic and normoxic
nitrite formation from NO in human lung epithelial cells.
& 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license. Once considered merely a toxic food additive and oxidation
product of nitric oxide (NO), nitrite has now been shown to exhibitr Inc.
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Open access under CC BY-important cell signaling functions in health and disease [1,2].
Recent studies reveal that nitrite functions as an endocrine
reservoir of NO present in plasma and tissues that can be reduced
to NO during physiological and pathological hypoxia, to regulate
important functions such as hypoxic vasodilation and cytoprotec-
tion [3,4]. During physiological and pathological hypoxia, nitrite is
converted to NO via reactions with hemoglobin, myoglobin,
neuroglobin, xanthine oxidoreductase, and other heme- and
thiol-containing enzymes and by acidic reduction [1,2,5–13].
Although nitrite is present in human plasma and organs, the
mechanisms of nitrite formation in vivo are not clear. Traditionally,
autoxidation of NO was thought to be a primary route of nitrite
formation; however, these reactions are too slow to compete with
other faster reactions, such as the reaction of NO with oxygenated
hemoglobin (oxy-Hb) [14]. Recent data from our laboratoryNC-ND license. 
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ceruloplasmin (Cp) to form nitrosonium cation (NO+), which
subsequently forms nitrite [15]. The high concentrations and high
oxidase activity of Cp in plasma have been shown to effectively
oxidize NO to nitrite and compete with the reaction of red cell
oxy-Hb with NO to form nitrite [15].
Cp is a blue-colored plasma protein that binds up to 95% of
circulating copper [16]. The proposed physiological functions of Cp
include copper transport, oxidation of organic amines, ferroxidase
activity, regulation of cellular iron levels, glutathione peroxidase,
and ascorbate oxidase activities, as well as an antioxidant activity
[17]. Structurally, Cp is an α-glycoprotein composed of a single-
chain polypeptide of 1046 amino acids and has a molecular weight
of approximately 132 kDa [18]. There are two forms of Cp; one is a
secretory form that is an acute-phase soluble protein mainly
synthesized in the liver and found predominantly in the plasma.
The other is expressed in the central nervous system of humans
and other mammals as a membrane-bound form [19]. In addition
to the liver, Cp is also expressed in various other tissues including
lung, brain, heart, spleen, testis, retina, thymus, and placenta, as
well as monocytic and epithelial cells [20,21].
In this study, we explored the mechanisms by which lung
epithelium can oxidize NO to nitrite. This question is of interest
based on observations that airway lining ﬂuid contains high
concentrations of nitrite and because plasma nitrite levels are higher
in the arterial blood than the venous blood, suggesting increased
nitrite formation in blood as it passes through the lung [15].Materials and methods
Chemicals and reagents
We purchased all chemicals from Sigma–Aldrich unless other-
wise stated. Lipopolysaccharide (LPS; from Escherichia coli 0111:
B4) was obtained from List Biological Laboratories, Inc. Recombi-
nant human IFN-γ, TNF-α, IL-1β, and monoclonal anti-human iNOS
antibody were obtained from R&D Systems. Puriﬁed mouse anti-
ceruloplasmin, mouse anti-COX-2, and mouse anti-AOX1 (alde-
hyde oxidase) antibodies were obtained from BD Transduction
Laboratories. Rabbit anti-β-actin antibody was purchased from Cell
Signaling. We purchased antibodies to sulﬁte oxidase (SO) and
xanthine oxidase (XO) from Santa Cruz Biotechnology, Inc. The
secondary antibodies for chemiluminescence detection were
obtained from Li-Cor Biosciences. Puriﬁed human ceruloplasmin
was acquired from Athens Research & Technology. The NO donor
DETA NONOate was purchased from Cayman Chemical. Human
oxy-Hb was puriﬁed from human blood in our laboratory.
Cell culture and treatments
The human lung adenocarcinoma epithelial cell line A549 was
purchased from the American Type Culture Collection and grown
in Dulbecco's modiﬁed Eagle's medium (DMEM; Invitrogen) sup-
plemented with 10% (v/v) FBS (fetal bovine serum; Invitrogen),
2 mM glutamine, and 1 penicillin–streptomycin (Invitrogen) in
an atmosphere of 95% air/5% CO2 at 371C. The cells were treated
with or without LPS (1 μg/ml) and cytokine mixture (TNF-α, IFN-γ,
and IL-1β, 20 ng/ml each) for up to 24 h before harvest of the
conditioned media and cells for nitrite measurement and Western
blotting. Primary human bronchial epithelial (HBE) cells were
cultured from excess pathological tissue after lung transplantation
and organ donation under a protocol approved by the University of
Pittsburgh Investigational Review Board. HBE cells were cultured
on human placental collagen-coated Costar Transwell ﬁlters in
bronchial epithelial growth medium as previously described byMyerburg et al. [22]. The cells were used for experimentation after
4–6 weeks of culture at an air–liquid interface.
For the heat-denatured A549 cells and heme protein inhibition
experiments, A549 cells (1  106/well) were cultured in six-well
plates with regular DMEM growth medium (10% FBS and glucose)
for 24 h. The cells were then washed twice with phosphate-
buffered saline (PBS) and cultured with serum-deprived DMEM.
For the heat-denatured A549 cells group, the cells were trypsi-
nized and resuspended in complete DMEM growth medium. After
the cells were washed two times with PBS, they were heat-
denatured at 95 1C for 10 min. The cells were then added back to
the culture plate wells with serum-deprived DMEM. Each well was
given DETA NONOate (50 mM). ODQ (30 μM) and sodium cyanide
(NaCN; 50 μM) were also added to respective wells with A549
cells. The culture plate was incubated in a CO2 incubator (21% O2,
5% CO2) for 24 h.
Western blotting analysis
Cells were washed twice with ice-cold PBS and lysed in NP-40
buffer supplemented with a protease inhibitor cocktail (Roche).
The cell lysates were resolved using 4–12% Bis–Tris SDS–PAGE gels
(Invitrogen) and transferred to nitrocellulose membranes (Bio-
Rad). The membrane was then probed with primary antibodies
speciﬁc to the target proteins. After incubation with the secondary
antibodies from Li-Cor Biosciences, the ﬂuorescent signals were
detected by an Odyssey scanner.
Nitrite, nitrate, and S-nitrosothiol (SNO) measurement
Nitrite, nitrate, and S-nitrosothiols were measured using reduc-
tive chemiluminescence in a Sievers 280i nitric oxide analyzer
(NOA; from GE Analytical Instruments) [23–26]. The protocol
published in Free Radical Research by Yang et al. [27] was followed
for SNO measurement.
Cp siRNA transfection
Dharmacon Accell siRNA against human Cp and scrambled
siRNA control were purchased from Thermo Scientiﬁc. The Accell
delivery medium (Thermo Scientiﬁc) was used for the transfection
according to the manufacturer's instructions.
Oxygen exposure assay
A549 cells (2  106 cells/ml/well) were plated in six-well
culture plates for up to 24 h under normoxic (21% O2) and hypoxic
(1% O2) conditions. The cells were treated with or without LPS/
cytokine mixture for 24 h. The cells and conditioned media were
harvested for Western blotting and nitrite measurement,
respectively.
Measurement of amine oxidase activity
Wemeasured ceruloplasmin activity spectrophotometrically by
monitoring the oxidation of p-phenylenediamine (PPD) at 530 nm
in the presence of A549 cell lysate, puriﬁed human Cp, and
concentrated medium as described by Sunderman et al. [28].
Statistical analysis
All data are presented as the mean 7 SD. Signiﬁcance was
estimated using Student's t test or ANOVA followed by the Tukey
multiple comparison procedure with p o 0.05 being considered
signiﬁcant.
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NO oxidase activity of A549 and HBE cells generates nitrite
and nitrate
To investigate whether A549 and HBE cells possess the ability
to convert NO to nitrite/nitrate, and the effect of oxygen reactions
on nitrite/nitrate formation, we incubated the NO donor DETA
NONOate (50 mM, with a half-life of about 20 h at 37 1C) with or
without A549 or HBE cells for 24 h under normoxic (21% O2) and
hypoxic (1% O2) conditions. As shown in Figs. 1 and 2, nitrite
(Fig. 1A and Fig. 2, top) and nitrate (Fig. 1B and Fig. 2, bottom)
production was signiﬁcantly increased in the presence of A549 or
HBE cells compared to NO donor exposure in the absence of cells
under various oxygen tensions, suggesting that both the lung
epithelial cell line and the primary cells have the capacity to
oxidize NO to nitrite/nitrate even under low-oxygen conditions.
Using a protocol to isolate A549 cell membrane proteins and
cytosolic proteins we next evaluated which fraction exhibited the
NO oxidase activity. After correction for protein concentration in
the fractions the results suggested that the membrane proteins
had the highest NO oxidase activity, converting NO to nitrite
(Fig. 1C) and nitrate (Fig. 1D). Protein size fractionation suggested
the highest oxidase activity was in the fraction o100 kDa in size
(Fig. 1E and F).Fig. 1. A549 cells have the ability to make nitrite and nitrate from NO. NO donor was inc
well plates with regular DMEM growth medium (10% FBS and glucose) for 24 h. Before th
and the culture medium was replaced with serum-deprived DMEM. The cells were then
CO2) for 24 h after DETA NONOate was added. (A) Nitrite and (B) nitrate levels in cond
methods). The cell protein was extracted from the cytoplasmic and membrane fraction
measured. The membrane fraction had the highest NO oxidase, converting NO to (C) ni
activity was in the fraction o100 kDa in size. np o 0.05, nnp o 0.01, and nnnp o 0.001A549 cells exhibit minimal nitrite consumption
To investigate a role for differential nitrite reduction or oxida-
tion (i.e., nitrite consumption), A549 cells (1  106/well) were
cultured in six-well plates with regular DMEM growth medium
(10% FBS and glucose) for 24 h. The cells were then washed twice
with PBS and cultured with serum-deprived DMEM. A cell-free
well with DMEM only was also set up as a control. Sodium nitrite
at 50 μM was added to the wells with or without A549 cells. The
culture plate was incubated in a CO2 incubator (21% O2, 5% CO2) for
24 h. As shown in Fig. 3, there was minimal nitrite consumption by
A549 cells.
Effects of ODQ, cyanide, and heat-denatured A549 cells on nitrite
and nitrate production in A549 cells
To demonstrate whether an enzymatic activity is involved in
the conversion of NO to nitrite, we heat-denatured A549 cells and
measured nitrite and nitrate formation. We found that heat-
denatured A549 cells almost abolished both nitrite and nitrate
formation, suggesting enzymatic activity is required for cellular
NO oxidation (Fig. 4). Furthermore, we treated A549 cells with
heme inhibitors (ODQ and cyanide) and observed signiﬁcant
inhibition of nitrite formation, indicating heme-containing pro-
teins may partially contribute to NO oxidation (Fig. 4).ubated with and without A549 cells. A549 cells (1  106/well) were cultured in six-
e cells were treated with DETA NONOate (50 mM), they were washed twice with PBS
placed in a regular CO2 incubator (21% O2, 5% CO2) or a hypoxic chamber (1% O2, 5%
itioned medium were then measured with a Sievers 280i NOA (see Materials and
s and similarly exposed to the NO donor for 24 h and the nitrite and nitrate were
trite and (D) nitrate. (E, F) Protein size fractionation suggested the highest oxidase
compared to respective controls.
Fig. 2. Primary human bronchial epithelial (HBE) cells converted NO to nitrite and
nitrate. NO donor was incubated with and without HBE cells. The cells were
cultured on human placental collagen-coated Costar Transwell ﬁlters with com-
plete DMEM/F-12 growth medium for 24 h. Before the cells were treated with DETA
NONOate (50 mM), they were washed twice with PBS and the culture medium was
replaced with serum-deprived DMEM/F-12 medium. The cells were then placed in
a regular CO2 incubator (21% O2, 5% CO2) or a hypoxic chamber (1% O2, 5% CO2) for
24 h after DETA NONOate (50 μM) was added. Nitrite (top) and nitrate (bottom)
levels in conditioned medium were then measured (see Materials and methods).
Fig. 3. Nitrite consumption in A549 cells. A549 cells (1  106/well) were cultured
in six-well plates with regular DMEM growth medium (10% FBS and glucose) for
24 h. The cells were then washed twice with PBS and cultured with serum-
deprived DMEM. A cell-free well with DMEM only was also set up as a control.
Sodium nitrite at 50 μM was added to the wells with or without A549 cells. The
culture plate was incubated in a CO2 incubator (21% O2, 5% CO2) for 24 h. Nitrite
levels in conditioned medium were then measured (see Materials and methods).
X.-J. Zhao et al. / Free Radical Biology and Medicine 61 (2013) 428–437 431Puriﬁed human Cp converts NO to nitrite/nitrate in A549 cells
To study the possibility of NO oxidation to nitrite/nitrate by
puriﬁed human Cp in A549 cells, the cells (1  106/well) were
cultured in six-well plates with regular DMEM growth medium
(10% FBS and glucose) for 24 h. The A549 cells were then washed
twice with PBS and cultured with serum-deprived DMEM. After
puriﬁed human Cp (0–500 mg/ml) and DETA NONOate (50 mM)were added, the cells were placed in a regular CO2 incubator
(21% O2, 5% CO2) for 24 h. As shown in Fig. 5, puriﬁed human Cp
increased nitrite (Fig. 5A) and nitrate (Fig. 5B) production in a
dose-dependent manner, which strongly suggests that Cp has NO
oxidase activity in vitro and that this effect could be measured in
this system.
Expression of Cp and iNOS and nitrite production in A549 cells
Cp has been shown to possess NO oxidase and nitrite synthase
activity in plasma [15] and NO oxidase and S-nitrosothiol synthase
activity in cells [29–31]. We hypothesized that Cp may function as
an NO oxidase in A549 cells. We ﬁrst measured Cp and iNOS
expression in A549 cells, in the presence or absence of LPS/
cytokine mixtures, over a 24-h time course. The expression of Cp
in both the cell lysates and the conditioned mediumwas measured
by Western blotting. There was a time-dependent increase in Cp
expression in both the cell lysates and the conditioned medium
with or without LPS/cytokine stimulation (Fig. 6A). In contrast,
iNOS was expressed in A549 cells only after LPS/cytokine stimula-
tion (Fig. 6B). We further observed a time-dependent increase in
nitrite production in conditioned medium from A549 cells after
LPS/cytokine stimulation (Fig. 6C), related to increases in iNOS-
dependent NO generation. These studies indicate that A549 cells
serve as an appropriate model for studying the role of Cp as an NO
oxidase in cell systems under basal and high iNOS expression
conditions.
Enhanced expression of Cp, iNOS, and COX-2 and decreased nitrite
concentration under hypoxic conditions in A549 cells
Because oxygen is a determinant of NO production rates based
on a requirement for de novo NO synthesis (oxygen and L-arginine
representing obligate substrates for NO synthesis by NO synthase),
we characterized the role of hypoxia in regulating the expression
of Cp, iNOS, and COX-2, as well as nitrite production, in A549 cells.
The cells were treated with or without LPS/cytokines for 24 h
under normoxic (21% O2) or hypoxic (1% O2) conditions.
As illustrated in Fig. 7A, we found that the expression of Cp and
COX-2 was increased by hypoxia both with and without LPS/
cytokine stimulation. We also observed that hypoxia enhanced the
expression of iNOS after stimulation. There was no expression of
iNOS without stimulation, under either normoxic or hypoxic
conditions. In addition, nitrite production was signiﬁcantly atte-
nuated (Fig. 7B) under hypoxic conditions, despite increases in
iNOS protein levels. These data indicate that oxygen can modulate
both the expression of proteins such as Cp, iNOS, and COX-2 and
the formation of nitrite. Based on the limited effects of hypoxia on
the formation of nitrite during NO donor exposure (Fig. 1), the
changes in nitrite formation seem to relate to oxygen availability
for de novo NO formation from iNOS (reported Km for oxygen
of 6.3 7 0.9 mM [32,33]), rather than reduced NO reactions with
oxygen (autoxidation reaction).
Human oxy-Hb scavenges NO production in A549 cells
to reduce nitrite
To conﬁrm that nitrite formed directly from NO we exposed
cells to increasing concentrations of oxy-Hb. Human oxy-Hb was
evaluated to test its effect on scavenging NO and expression of
iNOS. Nitrite concentrations in conditioned medium were mea-
sured with the NOA. The recorded NO (mV) trace by NOA from NO
produced in the headspace of the reaction chamber is shown in
Fig. 8A. Corresponding nitrite concentration in the conditioned
medium for each sample was calculated accordingly and is shown
in Fig. 8B. As shown in Fig. 8, NO was scavenged by oxy-Hb, which
Fig. 4. Effects of ODQ, cyanide, and heat-denatured A549 cells on nitrite and nitrate production in A549 cells. A549 cells (1  106/well) were cultured in six-well plates with
regular DMEM growth medium (10% FBS and glucose) for 24 h. The cells were then washed twice with PBS and cultured with serum-deprived DMEM. For heat-denatured
A549 cells, the cells were trypsinized and resuspended in complete DMEM growth medium. After the cells were washed two times with PBS, A549 cells were heat-denatured
at 95 1C for 10 min. The cells were then added back to the culture plate wells with serum-deprived DMEM. Each well was given DETA NONOate (50 mM). ODQ (30 μM) or
sodium cyanide (NaCN; 50 μM) was also added to respective wells with A549 cells. The culture plate was incubated in a CO2 incubator (21% O2, 5% CO2) for 24 h. Nitrite and
nitrate levels in conditioned mediumwere then measured (see Materials and methods). The top shows nitrite and nitrate levels before DMEM normalization. The normalized
levels are shown at the bottom. np o 0.05, nn;p o 0.01, and nnnp o 0.001 compared to respective controls.
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(Fig. 8A and B). However, lower concentrations of oxy-Hb showed
little effect on iNOS protein expression in A549 cells (Fig. 8C).Effect of Cp siRNA knockdown on nitrite and SNO formation
in A549 cells
To identify whether Cp is an NO oxidase that converts NO to
nitrite, we established a Cp knockdown cell model with A549 cells
that can reduce the expression of Cp to approximately 25%
compared to the scrambled siRNA control (Fig. 9A and B), without
affecting expression of other enzymes such as iNOS, SO, XO, and
AO (Fig. 9C). Because our previous in vivo study revealed that Cp
can compete with the NO–hemoglobin reaction to oxidize NO to
nitrite [15], we also performed a competition experiment with Cp
and oxy-Hb in A549 cells. Previous studies demonstrated that the
NO oxidase activity of Cp increased nitrite formation in plasma
[15] and SNO formation in cells [29–31]. To test our hypothesis that
Cp is an NO oxidase in A549 cells, we measured both nitrite and
SNO concentrations in conditioned medium and cell lysates after
treatment with Cp siRNA, with or without human oxy-Hb (20 mM).
After 24 h of LPS/cytokine stimulation, together with or without
oxy-Hb, the production of nitrite and SNO was determined by
ozone-based chemiluminescence analysis. Oxy-Hb signiﬁcantly
inhibited nitrite production, but Cp siRNA showed no effect on
nitrite formation in either conditioned medium or cell lysates
(Fig. 10A and B). We observed no signiﬁcant difference in SNO
formation by Cp siRNA and oxy-Hb in cell lysates (Fig. 10C).A549 cells exhibit little PPD oxidase activity because of limited
Cp expression
PPD oxidation is used to quantify the activity of Cp by measur-
ing the purple oxidation product of PPD directly via spectro-
photometry [34]. We therefore measured PPD oxidase activity by
using both cell lysates and conditioned medium from A549 cells.
No PPD oxidase activity was detected from A549 cells, whereas
human serum, a positive control, showed robust activity (Fig. 11A),
which is consistent with our previous reports [15]. We further
determined the protein amount of Cp presented in A549 cells by
comparing it to puriﬁed human Cp. As illustrated in Fig. 11B, we
found that the content of Cp in A549 cells was very low, which
resulted in limited PPD activity (Fig. 11C). Therefore, it is reason-
able to conclude that Cp may not exhibit sufﬁcient NO oxidase
activity in A549 cells because of a very low amount of Cp present
in these cells. These studies suggest that alternative NO oxidases
determine hypoxia and normoxic nitrite formation from NO in
human lung epithelial cells.Discussion
It is now appreciated that nitrite (NO2−) is a bioactive endocrine
form of NO that circulates in plasma and is concentrated in red
cells and organ tissues and that can mediate hypoxic physiolo-
gical responses and modulate the cellular responses to ischemia
[5,35,36]. Nitrite is reduced to NO by several mechanisms in vivo,
including acidic disproportionation and enzymatic reduction by
heme-containing globins (hemoglobin, myoglobin, neuroglobin)
Fig. 5. Ceruloplasmin converts NO to nitrite and nitrate. A549 cells (1  106/well)
were cultured in six-well plates with regular DMEM growth medium (10% FBS and
glucose) for 24 h. The cells were then washed twice with PBS and cultured with
serum-deprived DMEM. After puriﬁed human ceruloplasmin (0–500 mg/ml) and
DETA NONOate (50 mM) were added, the A549 cells were placed in a regular CO2
incubator (21% O2, 5% CO2) for 24 h. Nitrite and nitrate levels in conditioned
medium were then measured with a Sievers 280i NOA (see Materials and
methods). nnp o 0.01 compared to respective controls.
Fig. 6. Expression of Cp and iNOS and nitrite production in A549 cells under normoxia. A
24 h with serum-deprived DMEM. (A) Cp expression in both the cell lysates and th
conditioned medium). We also measured (B) iNOS expression in cell lysates and (C) nit
np o 0.05 and nnp o 0.01 compared to 6-h control.
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hyde oxidase) [6–8,35,38–43]. These mechanisms contribute to
hypoxic vasodilation, cytoprotection after ischemia–reperfusion
injury, and modulation of mitochondrial respiration [2,35,37,44–
47]. Given the role of nitrite as an important hypoxic signaling
molecule, a better understanding of the mechanisms responsible
for nitrite homeostasis (both formation and metabolism) is
essential.
Although nitrite concentrations in human plasma and erythro-
cytes are known to be maintained within a narrow range (121 7
9 and 288 7 47 nM, respectively), are conserved across many
mammalian species, and are present in airway lining ﬂuid, the
mechanism of nitrite formation in cells has not been determined.
The classical pathway for nitrite formation is autoxidation of NO,
which has been considered the primary route of nitrite formation,
based on the fact that this reaction occurs in oxygenated aqueous
buffers. However, this route of formation is kinetically implausible
at physiological oxygen concentrations, especially in the presence
of NO scavenger molecules such as hemoglobin. Hemoglobin
present in blood reacts with NO at nearly diffusion-limited rates
(3.4  107 M−1 s−1) to form inert nitrate (NO3−) [48,49]. For
comparison, the calculated half-time for the third-order NO
autoxidation reaction (K ¼ 2  106 M−2 s−1) at physiological NO
and oxygen concentrations (400 and 150 mM, respectively) is
greater than 30 min, suggesting that this pathway is not favorable
in vivo, where molecules such as hemoglobin would react with NO
much faster. Note also that this reaction pathway becomes even
less important under hypoxic conditions studied here. These
considerations suggest that a mechanism for metal-based catalysis
of nitrite synthesis and a speciﬁc NO oxidase activity must exist to
account for formation of nitrite in cell systems and organs.
Consistent with such a pathway, we previously reported that the
multi-copper oxidase, ceruloplasmin, can serve this purpose,
competitively oxidizing NO to NO+ and nitrite in plasma [15].
Using ceruloplasmin-knockout mice we found that this enzyme
regulated nitrite levels and the biological response to ischemia and
reperfusion injury. In this study we investigated the NO oxidase
activity of lung epithelium and explored a putative role for NO549 cells were cultured in the presence or absence of LPS/cytokine mixture for up to
e concentrated conditioned medium was determined by Western blotting (CM,
rite production in conditioned medium by Western blotting and NOA, respectively.
Fig. 7. Hypoxia enhanced expression of Cp, iNOS, and COX-2 and decreased nitrite production in A549 cells. A549 cells were treated with or without LPS/cytokine mixture
for 24 h under normoxic (21% O2) or hypoxic (1% O2) conditions with serum-deprived DMEM. (A) The expression of Cp, iNOS, and COX-2 was detected by Western blotting.
(B) The nitrite levels in conditioned medium were measured by NOA. np o 0.05 and nnp o 0.01 compared to respective controls.
Fig. 8. NO was scavenged by human oxy-Hb in a dose-dependent manner with little effect on iNOS expression. A549 cells (5  105/ml/well) were plated in 12-well plates
and cultured with complete DMEM growth medium for 24 h. The medium was then replaced with serum-deprived DMEM before treatment with various concentrations of
human oxy-Hb for 24 h in the presence of LPS/cytokine mixture. (A, B) Nitrite levels in conditioned medium were measured with a Sievers 280i NOA. (C) iNOS expression
was determined by Western blotting.
X.-J. Zhao et al. / Free Radical Biology and Medicine 61 (2013) 428–437434oxidases and speciﬁcally for the multi-copper oxidase ceruloplasmin
in nitrite homeostasis.
In this study we found that upon exposure of NO to buffer and
cell culture systems, the nitrite levels were increased in the
presence of cells, independent of oxygen tension. The ﬁnding that
nitrite formation is not affected by oxygen upon addition of NO
solutions suggests that NO autoxidation is unlikely to signiﬁcantly
account for observed formation of nitrite and that cells help
catalyze nitrite formation from NO. The loss of ability to oxidize
NO to nitrite and nitrate by heat-denatured A549 cells suggests
enzymatic activity accounts for cellular NO oxidation in lung
epithelium. We then evaluated endogenous NO formation fromiNOS using cytokine-stimulated conditions. We found that hemo-
globin inhibited nitrite formation, conﬁrming that nitrite derived
from NO, and the formation could be blocked with an NO
scavenger. The levels of nitrite produced from iNOS were reduced
at low oxygen, consistent with published Km values of iNOS for
oxygen, with reduced NO formation as oxygen levels drop. To test
a role for ceruloplasmin in the NO oxidation by cells, we knocked it
down with speciﬁc siRNA. Despite a clear knockdown effect, the
nitrite levels were unchanged under basal conditions and in
competition assays with oxyhemoglobin. Consistent with a lack
of effect on nitrite levels, the measured ceruloplasmin oxidase
activity in cells was very low, much lower than that observed in
Fig. 9. (A, B) Cp siRNA signiﬁcantly knocked down Cp protein expression with (C) no detectable effects on the expression of iNOS, SO, XO, or AO. A549 cells (1  105/ml/well)
were plated in 12-well plates. The cells were transfected with Dharmacon Accell siRNA against human Cp (1 mM) and scrambled siRNA control by using Accell delivery
medium (Thermo Scientiﬁc) for 5 days before the cells were harvested for Western blotting analysis.
Fig. 10. Effects of Cp siRNA and human oxy-Hb on nitrite and SNO formation in A549 cells. A549 cells were transfected with Cp siRNA (1 mM) or scrambled siRNA control
using Accell delivery medium (Thermo Scientiﬁc) in 12-well plates with cells 1  105/ml/well. After transfection, the complete culture medium was replaced with serum-
deprived DMEM and human oxy-Hb (20 mM) was added to the cells together with LPS/cytokine mixture for 24 h. Nitrite levels in (A) conditioned medium and (B) cells, as
well as SNO production in cells (C), were measured with NOA. np o 0.05 and nnp o 0.01 compared to controls.
X.-J. Zhao et al. / Free Radical Biology and Medicine 61 (2013) 428–437 435
Fig. 11. A549 cells exhibited no detectable PPD oxidase activity because of limited Cp expression. Each 75-cm2 cell culture ﬂask containing either A549 or HepG2 cells was
incubated in a hypoxic chamber (1% O2) for 24 h. Cell lysates and concentrated conditioned medium from each ﬂask were used for PPD oxidase activity assay with human
serum as a positive control. (A) PPD oxidase activity was barely detectable from either cell lysates or conditioned medium (CM), whereas high activity was observed in
human serum. (B) Cp protein expression from A549 cell lysates was then detected by Western blotting using puriﬁed human Cp protein as a positive control. The Cp content
in A549 cells was estimated to be less than about 0.05% of total protein by comparing with the puriﬁed human Cp protein. (C) PPD oxidase activity by puriﬁed human Cp was
observed to be dose-dependent, with no activity found in A549 and HepG2 cells (500 mg total protein per lysate sample), which indicates that a Cp amount of at least more
than 1 mg is required for detectable PPD oxidase activity.
X.-J. Zhao et al. / Free Radical Biology and Medicine 61 (2013) 428–437436plasma, in which this activity has been shown to regulate nitrite
levels [15], suggesting there is not enough Cp in lung epithelial
cells to functionally regulate nitrite formation. We further found
that membrane protein in A549 cells had the highest NO oxidase
activity. In addition, nitrite formation was inhibited by heme
inhibitors (ODQ and cyanide), indicating that heme-containing
proteins may partially contribute to NO oxidation in lung
epithelial cells.
In conclusion, these studies suggest that although NO produc-
tion by iNOS in lung epithelial cells is regulated by oxygen tension,
required as a substrate for de novo NO synthesis, the actual
metabolic fate of NO is largely independent of oxygen concentra-
tions. The NO is oxidized by cellular proteins that are concentrated
in the membrane fraction and less than 100 kDa in size. The
enzyme that oxidizes NO to nitrite in lung epithelial cells is not Cp,
based on the low concentrations and oxidase activity in these cells
compared with plasma. Future studies are required to identify the
speciﬁc oxidase that is responsible for NO conversion to nitrite and
nitrate in lung epithelial cells.Acknowledgments
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